Lanean...
A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2
The COVID-19 pandemic calls for rapid development of effective treatments. Although various drug repurpose approaches have been used to screen the FDA-approved drugs and drug candidates in clinical phases against SARS-CoV-2, the coronavirus that causes this disease, no magic bullets have been found...
Gorde:
| Argitaratua izan da: | Brief Bioinform |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8195169/ https://ncbi.nlm.nih.gov/pubmed/34081143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/bib/bbab211 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|